PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
Clinical trial NCT01056172 · UNKNOWN
Trial details
- NCT number
- NCT01056172
- Sponsor
- Pusan National University Yangsan Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2012-06-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.